*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Relationship of Femoral Neck with Age Group of Study to Recognize the Prevalence of Osteoporosis in Patients

Author: G. RAJAGURU, C. ARUN GANESH
Abstract: Now currently more than 25 million men and women Have osteoporosis, a metabolic bone disease categorized by using low bone compactness and deterioration of bone architecture that increase the chance of fractures. Osteoporosis-associated fractures can boom pain, disability, nursing domestic placement, general health care prices, and mortality. The prognosis of osteoporosis is typically decided through determining bone mineral density (BMD) the usage of noninvasive twin-strength x-ray absorptiometry. Osteoporosis medications consist of bisphosphonates, receptor activator of nuclear component kappa-B ligand inhibitors, estrogen agonists/antagonists, parathyroid hormone analogues, and calcitonin. Emerging cures utilizing novel mechanisms consist of a cathepsin K inhibitor and a monoclonal antibody in opposition to sclerostin. While expert companies have compiled suggestions for the organization of osteoporosis in numerous in habitants, a agreement has yet to increase as to which the gold is preferred; consequently, economic opinions had been an increasing number of important to help guide choice-makers. This research work proposes association of femoral neck with age group of study to know the prevalence of regional osteoporosis in patients.
Keyword: Sclerostin, Kappa-B Lig and Inhibitors, Estrogen Agonists/Antagonists, Parathyroid Hormone Analogues, and Calcitonin.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.212
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free